Posted February 4, 2008
BioMarck
BioMarck Receives FDA Approval for Phase II Trial of Lung Drug
Post a comment
Print this storyE-mail story
Share
BioMarck
Research Triangle Park, N.C. —
RTP startup is utilizing technology developed at NCSU for drug that could treat cause, not just symptoms, of chronic obstructive respiratory disease....Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
